HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $34,486 | +1.0% | 903 | +50.5% | 0.00% | 0.0% |
| Q4 2022 | $34,140 | +3314.0% | 600 | +3650.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -88.9% | 16 | -95.3% | 0.00% | – |
| Q3 2020 | $9,000 | -35.7% | 339 | -58.3% | 0.00% | -100.0% |
| Q3 2019 | $14,000 | 0.0% | 812 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $14,000 | +7.7% | 812 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $13,000 | +8.3% | 812 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $12,000 | -20.0% | 812 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $15,000 | +7.1% | 812 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $14,000 | -72.5% | 812 | -68.9% | 0.00% | -75.0% |
| Q1 2018 | $51,000 | -30.1% | 2,612 | -27.7% | 0.00% | -33.3% |
| Q4 2017 | $73,000 | -27.7% | 3,612 | -37.7% | 0.01% | -50.0% |
| Q3 2017 | $101,000 | – | 5,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |